GEXVal CEO to Present at BIO Asia-Taiwan 2025
wpmaster
株式會社GEXVal
2025年7月15日
GEXVal CEO to Present at BIO Asia-Taiwan 2025 International Conference & Exhibition
GEXVal Inc. (President and CEO: Juran Kato, PhD; Location: Fujisawa, Kanagawa, Japan, hereinafter “GEXVal”) is pleased to announce that President and CEO Dr. Juran Kato will present at the BIO Asia-Taiwan 2025 International Conference & Exhibition, co-hosted by the Biotechnology Innovation Organization and Taiwan Bio Industry Organization, following an invitation from the Japan BioIndustry Association .
[Event Overview]
BIO Asia-Taiwan is one of the largest international biotechnology conferences in the Asia-Pacific region. The event brings together industry leaders, innovators, and investors through comprehensive sessions on technology, market trends, and funding opportunities. It creates a dynamic platform where cutting-edge biotech companies connect with global partners and investors, driving innovation and growth across the biotechnology ecosystem.
■ Presentation Details ■
|
Conference |
BIO Asia-Taiwan 2025 Regional Collaboration Forum- Japan Session “Gateway to Japanese Hottest Companies” |
|
Date |
July 24, 2025, 15:00-16:35 (Presentation: 15:45-16:00) |
|
Venue |
TaiNEX1 404, Taipei, Taiwan |
|
URL |
BIO Asia-Taiwan 2025 International Conference & Exhibition BIO Asia-Taiwan 2025 Regional Collaboration Forum |
[CEO Statement]
President and CEO Dr. Juran Kato states: "We are thrilled to participate in one of Asia's premier international biotech conferences, representing the innovative spirit of Japanese biotechnology. At GEXVal, we've developed a unique integrated approach that combines AI-driven drug discovery with clinical development, transforming how we address unmet medical needs across the Asia-Pacific region. This presentation offers an exciting opportunity to connect with like-minded international partners who share our commitment to improving global access to medicine, as we work together to shape the future of healthcare."
[About GEXVal]
GEXVal strives to create and develop innovative pharmaceuticals for unmet medical needs, ensuring Treatment Reaches the Unreached with focus on rare diseases and underserved medical conditions. By leveraging our proprietary AI-powered pharmacoinformatics technology, we illuminate paths to breakthrough therapies, identifying hidden potential in drug candidates to deliver life-changing medicines that bring new hope to patients and their families.
有關本事宜請諮詢:
Head of Corporate Office
Atsushi Sugizaki
info@gexval.com
